TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS financial statements, including revenue, expenses, and profit

The total revenue of 0A87 for the last quarter is 6.91 B USD, and it's 7.94% lower compared to the previous quarter. The net income of Q4 24 is -676.85 M USD.